Sabra Health Care REIT, Inc.
NASDAQ:SBRAREIT - Healthcare Facilities
-$0.11 today
- Market cap
- $5.40B
- Beta
- 0.63
- P/E (TTM)
- 29.0
- EPS (TTM)
- $0.62
- Dividend yield
- 6.69%
Volume 2.42M
Average 2.46M
SBRA Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Sabra Health Care REIT, Inc.NASDAQ: SBRA
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization growth accelerates
Q2 FY2026 depreciation & amortization of $56.38M rose 29.4% year over year, ahead of the +21.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 6.1% from the prior quarter. Over 3 fiscal years it compounded at -0.1% a year.
Context
- Depreciation & amortization amounted to 24.1% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +29.4% holds above the trailing-twelve-month pace of +21.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 187M USD
- Year-over-year change
- +10.2%
- 4-year CAGR
- +1.1%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 187M | +10.2% |
| FY2024 | 2024-12-31 | 169.62M | -7.4% |
| FY2023 | 2023-12-31 | 183.09M | -2.5% |
| FY2022 | 2022-12-31 | 187.78M | +4.9% |
| FY2021 | 2021-12-31 | 178.99M | — |
Depreciation & Amortization vs competitors
How SBRA compares with its peers on the latest reported figures
- SBRA's LTM Jun 2026 depreciation & amortization of $209.43M is the 7th highest of the 11 companies compared; the peer median is $280.38M.
- Its year-over-year change of +21.7% is the 5th highest of 9, against a peer median of +15.2%.
- Depreciation & amortization amounts to 24.4% of revenue for SBRA, versus a peer median of 22.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.68B | +33.1% | +17.0% | 19.6% | |
| LTM Sep 2026 | $1.1B | +2.4% | +12.9% | 48.9% | |
| LTM Jun 2026 | $330.85M | +4.6% | -0.7% | 25.6% | |
| LTM Sep 2026 | $312.23M | +43.2% | +3.9% | 11.7% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $281.95M | -26.8% | -7.6% | 27.7% |
| FY2025 | $278.81M | — | — | 36.2% | |
| LTM Jun 2026 | $209.43M | +21.7% | -0.1% | 24.4% | |
| LTM Sep 2026 | $120.29M | +58.9% | +22.7% | 19.5% | |
| LTM Sep 2026 | $98.11M | +25.8% | +5.8% | 21.5% | |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | $80.59M | — | -1.6% | 23.5% |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $72.29M | -19.5% | -1.3% | 21.1% |
| Peer median (excluding SBRA) | $280.38M | +15.2% | +3.9% | 22.5% | |
Competitors are the stored peer set for SBRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 569.55M | 624.81M | 647.51M | 703.24M | 774.63M |
| Cost of Revenue | 141.2M | 162.61M | 195.25M | 227.09M | 271.11M |
| Gross Profit | 428.34M | 462.2M | 452.27M | 476.15M | 503.53M |
| Gross Margin | 75.2% | 74.0% | 69.8% | 67.7% | 65.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 34.67M | 39.57M | 47.47M | 50.07M | 53.71M |
| Operating Expenses | 217.6M | 227.36M | 230.56M | 219.12M | 239.66M |
| Depreciation & Amortization | 178.99M | 187.78M | 183.09M | 169.62M | 187M |
| EBITDA | 166.21M | 216.89M | 311.81M | 412.61M | 456.83M |
| EBITDA Margin | 29.2% | 34.7% | 48.2% | 58.7% | 59.0% |
| Operating Income | 210.75M | 234.84M | 221.71M | 257.03M | 263.87M |
| Operating Margin | 37.0% | 37.6% | 34.2% | 36.5% | 34.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 98.63M | 105.47M | 112.96M | 115.27M | 112.49M |
| Other Income / Expenses | (322.16M) | (311.21M) | (205.95M) | (129.31M) | (106.52M) |
| Income Before Tax | (111.41M) | (76.36M) | 15.76M | 127.72M | 157.35M |
| Pre-Tax Margin | -19.6% | -12.2% | 2.4% | 18.2% | 20.3% |
| Income Tax Expense | 1.85M | 1.24M | 2M | 1.01M | 1.84M |
| Net Income | (113.26M) | (77.61M) | 13.76M | 126.71M | 155.61M |
| Net Margin | -19.9% | -12.4% | 2.1% | 18.0% | 20.1% |
| EPS (Basic) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| EPS (Diluted) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| Weighted Avg Shares | 219.07M | 230.95M | 231.2M | 233.5M | 241.31M |
| Weighted Avg Shares (Diluted) | 219.07M | 230.95M | 232.79M | 236.05M | 244.5M |
Sabra Health Care REIT, Inc.
NASDAQ:SBRA
Intrinsic Alpha fair value
Locked
Current Price
$20.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.